AAAAAA

   
Results: 1-18 |
Results: 18
A BAYESIAN NEURAL-NETWORK METHOD FOR ADVERSE DRUG REACTION SIGNAL GENERATION
Authors: BATE A LINDQUIST M EDWARDS IR OLSSON S ORRE R LANSNER A DEFREITAS RM
Citation: A. Bate et al., A BAYESIAN NEURAL-NETWORK METHOD FOR ADVERSE DRUG REACTION SIGNAL GENERATION, European Journal of Clinical Pharmacology, 54(4), 1998, pp. 315-321
BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTING ADVERSE DRUG-REACTIONS .8. RENAL AND URINARY SYSTEM DISORDERS
Authors: AELLIG W BANKOWSKI Z BAUMBAUER E BRUPPACHER R CONE M COVESMITH R DEBRE M EDWARDS IR GALLAGHER J GRABENSEE B IDANPAANHEIKKILA J KREMER G KREUTZ G KRUPP P LESKI M LUMPKIN MM OSTER M PFEIFFER M ROCCO F SAUER F SCHOU J SHRANK J SCHUMANN W SPIEGL W SPINELLI F SPRENGER K TENHAM M TRENQUE T VENULET J WEIDMANN E WEISS JM WOOD KL
Citation: W. Aellig et al., BASIC REQUIREMENTS FOR THE USE OF TERMS FOR REPORTING ADVERSE DRUG-REACTIONS .8. RENAL AND URINARY SYSTEM DISORDERS, Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 203-211
REASONS FOR REPORTING ADVERSE DRUG-REACTIONS - SOME THOUGHTS BASED ONAN INTERNATIONAL REVIEW
Authors: BIRIELL C EDWARDS IR
Citation: C. Biriell et Ir. Edwards, REASONS FOR REPORTING ADVERSE DRUG-REACTIONS - SOME THOUGHTS BASED ONAN INTERNATIONAL REVIEW, Pharmacoepidemiology and drug safety, 6(1), 1997, pp. 21-26
ADVERSE DRUG-REACTIONS - FINDING THE NEEDLE IN THE HAYSTACK - PHARMACOVIGILANCE IS IMPROVING - NOW WE NEED TO ENSURE THAT PATIENTS BENEFIT
Authors: EDWARDS IR
Citation: Ir. Edwards, ADVERSE DRUG-REACTIONS - FINDING THE NEEDLE IN THE HAYSTACK - PHARMACOVIGILANCE IS IMPROVING - NOW WE NEED TO ENSURE THAT PATIENTS BENEFIT, BMJ. British medical journal, 315(7107), 1997, pp. 500-500
HOW DOES CYSTITIS AFFECT A COMPARATIVE RISK PROFILE OF TIAPROFENIC ACID WITH OTHER NONSTEROIDAL ANTIINFLAMMATORY DRUGS - AN INTERNATIONAL STUDY BASED ON SPONTANEOUS REPORTS AND DRUG USAGE DATA
Authors: LINDQUIST M PETTERSSON M EDWARDS IR SANDERSON JH TAYLOR NFA FLETCHER AP SCHOU JS SAVAGE R
Citation: M. Lindquist et al., HOW DOES CYSTITIS AFFECT A COMPARATIVE RISK PROFILE OF TIAPROFENIC ACID WITH OTHER NONSTEROIDAL ANTIINFLAMMATORY DRUGS - AN INTERNATIONAL STUDY BASED ON SPONTANEOUS REPORTS AND DRUG USAGE DATA, Pharmacology & toxicology, 80(5), 1997, pp. 211-217
DANGERS OF NONSEDATING ANTIHISTAMINES - REPLY
Authors: LINDQUIST M EDWARDS IR
Citation: M. Lindquist et Ir. Edwards, DANGERS OF NONSEDATING ANTIHISTAMINES - REPLY, Lancet, 350(9070), 1997, pp. 69-70
RISKS OF NONSEDATING ANTIHISTAMINES (VOL 349, PG 1322, 1997)
Authors: LINDQUIST M EDWARDS IR
Citation: M. Lindquist et Ir. Edwards, RISKS OF NONSEDATING ANTIHISTAMINES (VOL 349, PG 1322, 1997), Lancet, 349(9063), 1997, pp. 1482-1482
RISKS OF NONSEDATING ANTIHISTAMINES
Authors: LINDQUIST M EDWARDS IR
Citation: M. Lindquist et Ir. Edwards, RISKS OF NONSEDATING ANTIHISTAMINES, Lancet, 349(9061), 1997, pp. 1322-1322
CAUSAL OR CASUAL - THE ROLE OF CAUSALITY ASSESSMENT IN PHARMACOVIGILANCE
Authors: MEYBOOM RHB HEKSTER YA EGBERTS ACG GRIBNAU FWJ EDWARDS IR
Citation: Rhb. Meyboom et al., CAUSAL OR CASUAL - THE ROLE OF CAUSALITY ASSESSMENT IN PHARMACOVIGILANCE, Drug safety, 17(6), 1997, pp. 374-389
THE CHALLENGE OF EFFECTIVELY COMMUNICATING RISK-BENEFIT INFORMATION
Authors: EDWARDS IR HUGMAN B
Citation: Ir. Edwards et B. Hugman, THE CHALLENGE OF EFFECTIVELY COMMUNICATING RISK-BENEFIT INFORMATION, Drug safety, 17(4), 1997, pp. 216-227
PRINCIPLES OF SIGNAL-DETECTION IN PHARMACOVIGILANCE (VOL 16, PG 360, 1997)
Authors: MEYBOOM RHB EGBERTS ACG EDWARDS IR
Citation: Rhb. Meyboom et al., PRINCIPLES OF SIGNAL-DETECTION IN PHARMACOVIGILANCE (VOL 16, PG 360, 1997), Drug safety, 17(2), 1997, pp. 118-118
PRINCIPLES OF SIGNAL-DETECTION IN PHARMACOVIGILANCE
Authors: MEYBOOM RHB EGBERTS ACG EDWARDS IR HEKSTER YA DEKONING FHP GRIBNAU FWJ
Citation: Rhb. Meyboom et al., PRINCIPLES OF SIGNAL-DETECTION IN PHARMACOVIGILANCE, Drug safety, 16(6), 1997, pp. 355-365
WITHDRAWAL REACTIONS WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS AS REPORTED TO THE WHO SYSTEM
Authors: STAHL MMS LINDQUIST M PETTERSSON M EDWARDS IR SANDERSON JH TAYLOR NFA FLETCHER AP SCHOU JS
Citation: Mms. Stahl et al., WITHDRAWAL REACTIONS WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS AS REPORTED TO THE WHO SYSTEM, European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 163-169
WHO CARES ABOUT PHARMACOVIGILANCE
Authors: EDWARDS IR
Citation: Ir. Edwards, WHO CARES ABOUT PHARMACOVIGILANCE, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 83-88
CONCEPTS IN RISK-BENEFIT ASSESSMENT - A SIMPLE MERIT ANALYSIS OF A MEDICINE
Authors: EDWARDS IR WIHOLM BE MARTINEZ C
Citation: Ir. Edwards et al., CONCEPTS IN RISK-BENEFIT ASSESSMENT - A SIMPLE MERIT ANALYSIS OF A MEDICINE, Drug safety, 15(1), 1996, pp. 1-7
THROMBOCYTOPENIA REPORTED IN ASSOCIATION WITH HEPATITIS-B AND HEPATITIS-A VACCINES
Authors: MEYBOOM RHB FUCIK H EDWARDS IR
Citation: Rhb. Meyboom et al., THROMBOCYTOPENIA REPORTED IN ASSOCIATION WITH HEPATITIS-B AND HEPATITIS-A VACCINES, Lancet, 345(8965), 1995, pp. 1638-1638
HARMONIZATION IN PHARMACOVIGILANCE
Authors: EDWARDS IR BIRIELL C
Citation: Ir. Edwards et C. Biriell, HARMONIZATION IN PHARMACOVIGILANCE, Drug safety, 10(2), 1994, pp. 93-102
NEW PHARMACOVIGILANCE INFORMATION ON AN OLD DRUG - AN INTERNATIONAL STUDY OF SPONTANEOUS REPORTS ON DIGOXIN
Authors: LINDQUIST M SANDERSON J CLAESSON C IMBS JL ROHAN A EDWARDS IR
Citation: M. Lindquist et al., NEW PHARMACOVIGILANCE INFORMATION ON AN OLD DRUG - AN INTERNATIONAL STUDY OF SPONTANEOUS REPORTS ON DIGOXIN, Drug investigation, 8(2), 1994, pp. 73-80
Risultati: 1-18 |